Red flags / Officer or director exit

TEVATeva Pharmaceutical Industries LimitedElevatedForm 8-Kfiled Nov 18, 5:07 PM ET

Teva's Chief Medical Officer Eric Hughes resigns effective immediately

Teva disclosed that Dr. Eric Hughes, Executive Vice President, Global R&D and Chief Medical Officer, notified the company on November 17, 2026 of his intention to resign and will step down immediately, staying on to assist with a transition over the next few months. The filing names no successor and gives no reason for the departure. Sudden exits of senior R&D leaders can raise questions about the continuity of the company's pipeline and clinical programs.

“Dr. Hughes will step down immediately from his role and will continue to assist with a smooth transition over the next few months.”

What the stock did

From the last close before the filing was public. Market cap now: $45.8B.

1 day
-8.7%
SPY -2.0%
5 days
Not yet
 
20 days
Not yet
 

8-K Item 5.02: a CEO, CFO or director left suddenly or over a disagreement. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.

Other flags on TEVA

FiledStockFlagWhat the filing saysMkt cap5 days20 days
Nov 12, 4:11 PM ETTEVA
Teva Pharmaceutical Industries Limited
Insider selling cluster
ElevatedForm 4
3 officers and directors sold $3.8M of Teva Pharmaceutical Industries Limited stock in 10 days$45.8B-11.7%-